Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice
المؤلفون المشاركون
Iapadre, Nerio
Coletti, Gino
Ficorella, Corrado
Giordano, Aldo Victor
Manetta, Rosa
Carducci, Sergio
Cannita, Katia
Bruera, Gemma
Saltarelli, Patrizia
Vicentini, Roberto
Ricevuto, Enrico
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-11، 11ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-05-08
دولة النشر
مصر
عدد الصفحات
11
التخصصات الرئيسية
الملخص EN
Background.
Hepatocellular carcinoma (HCC) patients require different treatment strategies according to disease extension, liver function, and patient’s fitness.
We evaluated HCC multidisciplinary management in clinical practice.
Methods.
Consecutive patients were followed and treated with tailored medical, locoregional, and surgical treatments, according to disease stage and patient’s fitness (age, Cumulative Illness Rating Scale (CIRS)).
Activity, efficacy, and safety were evaluated.
Results.
Thirty-eight patients were evaluated: median age, 74; elderly 92%; CIRS secondary 28 (74%); Child-Pugh A 20 (53%), B 11 (29%); and Barcelona Clinic Liver Cancer (BCLC) 0 2 (5%), A 9 (24%), B 10 (26%), C 13 (34%), and D 4 (11%).
Overall survival (OS) was 30 months.
At 9 months median follow-up, among 25 unresectable HCC, OS was 10 months; BCLC B–D unfit for sorafenib showed OS 3 months.
Ten patients (40%) received sorafenib: Child-Pugh A 5 (50%) and B 5 (50%) and disease control rate 89%, progression-free survival 7 months, and OS 9 months.
G3-4 toxicities: anorexia, hypertransaminaemia, hyperbilirubinemia, and hypercreatininemia.
Limiting toxicity syndromes were 40%, all multiple sites.
Conclusion.
HCC patients require multidisciplinary clinical management to properly select tailored treatments according to disease stage, fitness, and liver function.
Patients suitable for sorafenib should be carefully selected, monitored for individual safety, and prevalently characterized by limiting toxicity syndromes multiple sites.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Bruera, Gemma& Cannita, Katia& Giordano, Aldo Victor& Manetta, Rosa& Vicentini, Roberto& Carducci, Sergio…[et al.]. 2014. Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice. BioMed Research International،Vol. 2014, no. 2014, pp.1-11.
https://search.emarefa.net/detail/BIM-499562
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Bruera, Gemma…[et al.]. Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice. BioMed Research International No. 2014 (2014), pp.1-11.
https://search.emarefa.net/detail/BIM-499562
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Bruera, Gemma& Cannita, Katia& Giordano, Aldo Victor& Manetta, Rosa& Vicentini, Roberto& Carducci, Sergio…[et al.]. Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-11.
https://search.emarefa.net/detail/BIM-499562
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-499562
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر